Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01668134 · ClinicalTrials.gov registry record · Phase 1
Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma
A Phase 1 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
NCT01668134 is a Phase 1 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 28 participants.
The verdict
NCT01668134, a Phase 1 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
This study is being done to determine if targeted radiation therapy (stereotactic) can be given to treat liver cancer, for patient who are unable to undergo surgery, over a short period of time with a small amount of side effects.
Interventions
- RADIATION Stereotactic radiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2009-12-16 |
| Est. Completion | 2015-12-22 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01668134
The ClinicalTrials.gov registry entry for NCT01668134 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stereotactic radiation is the first listed.
NCT01668134 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01668134 about?
NCT01668134 is a clinical study titled "Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma". This study is being done to determine if targeted radiation therapy (stereotactic) can be given to treat liver cancer, for patient who are unable to undergo surgery, over a short period of time with a small amount of side effects.
What is the current status of trial NCT01668134?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2009-12-16. Estimated completion is 2015-12-22.
What interventions are being tested in trial NCT01668134?
The interventions under investigation include: Stereotactic radiation (RADIATION).
Who is sponsoring clinical trial NCT01668134?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.